Today, we have a brief program, Rhythm's Commercial Readiness for Acquired Hypothalamic Obesity, an event for investors. This morning, we'll hear from Dr. David Meeker, Rhythm's Chairman, CEO and ...
Analyst/Investor Day September 24, 2025 10:00 AM EDTCompany ParticipantsStephen Mikkelsen - Group CEO, Director & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback